The Clinton Herald, Clinton, Iowa

Top News

October 2, 2013

First pre-surgical breast cancer drug

WASHINGTON — A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease.

The Food and Drug Administration approved Perjeta for women with a form of early-stage breast cancer who face a high risk of having their cancer spread to other parts of the body.

Surgery to remove tumors is usually the first step in treating most forms of cancer. Perjeta is the first drug to be approved as a pre-surgical step.

Doctors hope that using cancer drugs earlier could help shrink tumors, making them easier to remove. In some cases, that could allow women to keep their breasts, rather than having a full mastectomy. Doctors also say that treating the disease at its earliest stages could prevent tumors from returning later, though studies have not yet established that benefit.

“By making effective therapies available to high-risk patients in the earliest disease setting, we may delay or prevent cancer recurrences,” said FDA’s Dr. Richard Pazdur, who directs the agency’s office of cancer products.

Cancer specialists already use several chemotherapy drugs as initial treatments for cancer, but they are not formally approved for the use. The FDA originally approved Perjeta to treat breast cancer that has spread to other parts of the body after surgery.

The FDA granted the drug accelerated approval for its new use based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations. Accelerated approval is reserved for drugs that show groundbreaking results for treating life-threatening diseases in early studies.

As a condition of approval, Roche’s Genentech unit must conduct a larger follow-up study showing the drug’s long-term benefits for patients. Generally that means showing that patients lived longer or had a higher quality of life due to taking the drug. Genentech, based in South San Francisco, Calif., has already enrolled about 4,800 patients in the follow-up study, with results expected in 2016.

Text Only
Top News
  • John Hood A year after 'chaos'

    It happened two hours after John Hood finished his run. Like many, he thought the loud boom was just the sound of cannons going off, something that shook the ground. It was odd, but Hood — a 1989 Clinton High School graduate — tried to make it logical, associating the noise with another good happening at the Boston Marathon.

    April 18, 2014 1 Photo

  • Why do wolves howl?

    Of all the myths that dog the wolf, none is more widely accepted than the idea that wolves howl at the moon. Images of wolves with their heads upturned, singing at the night sky, are as unquestioned as a goldfish's three-second memory or a dog's color-blindness (both also myths).

    April 18, 2014

  • Biggest student loan profits come from grad students

    This week, the Congressional Budget Office projected that the federal government would earn roughly $127 billion from student lending during the next 10 years.

    April 18, 2014

  • AGENDA: 4-22-14 Clinton City Council

    The Clinton City Council will meet Tuesday at 7 p.m. followed by a committee of the whole.

    April 18, 2014

  • Judge asks pointed questions in gay marriage case

    A judge in Colorado who will play a pivotal role deciding whether gays should be allowed to wed in the United States asked pointed questions Thursday about whether Oklahoma can legally ban the unions.

    U.S. Circuit Judge Jerome Holmes is seen as the swing vote on the three-judge panel that heard the Oklahoma appeal and a similar case from Utah last week.

    April 18, 2014

  • NASA's moon-orbiting robot crashes down as planned

    April 18, 2014

  • Eyewitness testimony no longer a gold standard

    The American legal system offers few moments as dramatic as an eyewitness to a crime pointing his finger across a crowded courtroom at a defendant.

    The problem is that decades of studies show eyewitness testimony is only right about half the time — a reality that has prompted a small vanguard of police chiefs, courts and lawmakers to toughen laws governing the handling of eyewitnesses and their accounts of crimes.

    April 18, 2014

  • Blagojevich campaign account donates final dollars

    A federal campaign account for imprisoned former Illinois Gov. Rod Blagojevich is now empty, two years into the Chicago Democrat's prison term.

    The (Arlington Heights) Daily Herald reports Friends of Rod Blagojevich donated $709.85 to a Serbian Orthodox Church monastery earlier this month.

    April 18, 2014

  • GOP lawmaker objects to 9-0 vote for Obama library

    A Republican lawmaker is protesting after an Illinois House committee recorded a 9-0 vote to commit $100 million for President Barack Obama's library and museum, even though the committee's four GOP members weren't there.

    Rep. Ed Sullivan of Mundelein says he didn't expect a vote during Thursday's hearing. He told WBEZ radio and the (Arlington Heights) Daily Herald he would've voted no.

    Sullivan says "the legacy of the Obama presidential library shouldn't be kicked off in a cloud of controversy."

    April 18, 2014

  • Prosecutor says 6 felon voting cases will proceed

    A prosecutor pursuing several cases against felons charged with voting illegally says an Iowa Supreme Court ruling shouldn't impact them.Assistant Black Hawk County Attorney Linda Fangman said Thursday the prosecutions will "proceed as is," despite Tuesday's ruling suggesting that not all felons lose their voting rights. She's handling felony election misconduct cases against six offenders accused of voting in the 2012 election even though they lost their rights. A seventh may plead guilty Monday.

    April 18, 2014

AP Video